Target pressure in glaucoma therapy

Journal of Glaucoma

Volumn 6, Issue 2, 1997, Pages 133-138

  Jampel, Henry D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; OPTIC NERVE LESION; PRIORITY JOURNAL; QUALITY OF LIFE;

COST-BENEFIT ANALYSIS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; OPTIC NERVE;

EID: 0030997509     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Brubaker R. Delayed functional loss in glaucoma. Am J Ophthalmol 1996;121:473-82.
2. Repka MX, Quigley HA. The effect of age on normal human optic nerve fiber number and diameter. Ophthalmology 1989;96:26-32.
3. Mikelberg FS, Drance SM, Schulzer M, Yidegiligne HM, Weis MM. The normal human optic nerve. Axon count and axon diameter distribution. Ophthalmology 1989;96:1325-8.
4. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
5. Quigley H, Tielsch JM, Katz J, Sommer A. The rate of progression in open-angle glaucoma. Am J Ophthalmol 1996 (in press).
6. Shin DH, Bielik M, Hong YJ, Briggs KS, Shi DX. Reversal of glaucomatous optic disc cupping in adult patients. Arch Ophthalmol 1989;107:1599-603.
7. Katz LJ, Spaeth GL, Cantor LB, Poryzees EM, Steinmann WC. Reversible optic disk cupping and visual field improvement in adults with glaucoma. Am J Ophthalmol 1989; 107:485-92.
8. The Fluorouracil Filtering Surgery Study Group. Fluorouracil Filtering Surgery Study one-year follow-up. Am J Ophthalmol 1989;108:625-35.
9. The Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 1990;97:1403-13.
10. Anderson D. Glaucoma: the damage caused by pressure. Am J Ophthalmol 1989;108:485-95.
11. Hodapp E, Parrish RP, Anderson D. Clinical decisions in glaucoma. St. Louis: C.V. Mosby; 1993:65.
12. Grant W, Burke J. Why do some people go blind from glaucoma? Ophthalmology 1982;89:991-8.
13. Taniguchi T, Kitazawa Y. A risk-benefit assessment of drugs used in the management of glaucoma. Drug Safety 1994; 11:68-74.
14. Wilensky JT, Gieser DK, Dietsche ML, Mori MT, Zeimer R. Individual variability in the diurnal intraocular pressure curve. Ophthalmology 1993;100:940-4.
15. Zeimer RC, Wilensky JT, Gieser DK, Viana MA. Association between intraocular pressure peaks and progression of visual field loss. Ophthalmology 1991;98:64-9.
16. Laibovitz R, Strahlman E, Barber B, Strohmaier K. Comparison of quality of life and patient preference of dorzolamide and pilocarpine as adjunctive therapy to timolol in the treatment of glaucoma. J Glaucoma 1995;4:306-13.